Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Gazzo

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2024
RB1 Genetic Alterations in Estrogen Receptor-Positive Breast Carcinomas: Correlation With Neuroendocrine DifferentiationChristopher J Schwartz, Antonio Marra, Pier Selenica, et al.
NPJ Precision Oncology|May 20, 2026
MYC contributes to targeted therapy resistance in lung cancers driven by MET exon 14-skipping alterationDaniel Lu, Sarah Okun, Tom Zhang, et al.
Research Square|June 30, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
NPJ Breast Cancer|July 21, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
The Journal of Pathology. Clinical Research|December 2, 2020
Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinomaTimothy M D'Alfonso, Fresia Pareja, Arnaud Da Cruz Paula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal CarcinomaFresia Pareja, David N Brown, Ju Youn Lee, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Genome Medicine|August 28, 2024
Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumorsYingjie Zhu, Xin Pei, Ardijana Novaj, et al.
JAMA Oncology|September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas CancerCatherine A O'Connor, Emily Harrold, David Lin, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2024
RB1 Genetic Alterations in Estrogen Receptor-Positive Breast Carcinomas: Correlation With Neuroendocrine DifferentiationChristopher J Schwartz, Antonio Marra, Pier Selenica, et al.
NPJ Precision Oncology|May 20, 2026
MYC contributes to targeted therapy resistance in lung cancers driven by MET exon 14-skipping alterationDaniel Lu, Sarah Okun, Tom Zhang, et al.
Research Square|June 30, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
NPJ Breast Cancer|July 21, 2025
Breast carcinomas associated with microglandular adenosis are linked to germline alterations in homologous recombination-deficiency genesChristopher J Schwartz, Iskender Genco, Matteo Repetto, et al.
The Journal of Pathology. Clinical Research|December 2, 2020
Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinomaTimothy M D'Alfonso, Fresia Pareja, Arnaud Da Cruz Paula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal CarcinomaFresia Pareja, David N Brown, Ju Youn Lee, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>RRAS</i> and <i>RRAS2</i> mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236Alexander J Pfeil, Tom Zhang, Ryan Cheng, et al.
Genome Medicine|August 28, 2024
Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumorsYingjie Zhu, Xin Pei, Ardijana Novaj, et al.
JAMA Oncology|September 5, 2024
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas CancerCatherine A O'Connor, Emily Harrold, David Lin, et al.
Pageof 3